442-L Development of Panck T cells, MR1-restricted pan-cancer-killing CD8+ T cells, as an adoptive T cell therapeutics

442-L Development of Panck T cells, MR1-restricted pan-cancer-killing CD8+ T cells, as an adoptive T cell therapeutics

Bibliographic Details
Main Authors:	Sunhee Hwang, Byoung S Kwon, Young H Kim, Yeeun Bak
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Biology of CD1- and MR1-restricted T cells.
by: Salio, M, et al.
Published: (2014)

Adoptive T cell therapy targeting CD1 and MR1
by: Tingxi eGuo, et al.
Published: (2015-05-01)

Unconventional functions of MR1 restricted T-cells
by: Delowar Akther, H
Published: (2022)

MR1-Restricted T Cells in Cancer Immunotherapy
by: Pedro Flores-Villanueva, et al.
Published: (2020-08-01)

Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells.
by: Archana Thakur, et al.
Published: (2012-01-01)

Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
by: Haihong Jin, et al.
Published: (2022-12-01)

CD56bright natural killer cells preferentially kill proliferating CD4+ T cells
by: Lee, M, et al.
Published: (2023)

Restriction of Glycolysis Increases Serial Killing Capacity of Natural Killer Cells
by: Lea Katharina Picard, et al.
Published: (2024-03-01)

Elevated CD54 expression renders CD4+ T cells susceptible to NK cell-mediated killing.
by: Chen, X, et al.
Published: (2019)

362 Allelic variants of MR1 drive cancer and allo-reactivity by MR1-restricted T cells
by: Sophie Papa, et al.
Published: (2023-11-01)

CD4(-)CD8alphaalpha subset of CD1d-restricted NKT cells controls T cell expansion.
by: Ho, L, et al.
Published: (2004)

Radiation-induced immunosuppressive macrophages limit CD8 T-cell mediated tumor killing
by: Jones, K, et al.
Published: (2018)

Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
by: Ester Fagnano, et al.
Published: (2023-10-01)

Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4+ TCR-T Cells
by: Yanling Liang, et al.
Published: (2022-07-01)

Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells in vitro and in vivo
by: Michael Valentine, et al.
Published: (2020-01-01)

1044 High dose of rhIL-10 enhances CD8 T cell and NK cell mediated tumor cell killing in vitro
by: Elli Narvi, et al.
Published: (2023-11-01)

Harnessing SARS‐CoV‐2‐specific CD8+ T cells to kill target tumor cells for cancer immunotherapy
by: Keunok Jung, et al.
Published: (2024-01-01)

Pigs that recover from porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8- T-cells that kill virus infected cells.
by: Chungwon J Chung, et al.
Published: (2018-01-01)

Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells
by: Kris Covens, et al.
Published: (2023-07-01)

Histone deacetylase inhibitors enhance CD4 T cell susceptibility to NK cell killing but reduce NK cell function
by: Pace, M, et al.
Published: (2016)

CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
by: Vita Golubovskaya, et al.
Published: (2017-10-01)

Identification of biomarkers associated with CD8+ T cells in rheumatoid arthritis and their pan-cancer analysis
by: Zhenyu Zhao, et al.
Published: (2022-11-01)

442-O Identifying cancer-specific T cells for immunotherapy through engineered proteins
by: Rongyu Zhang
Published: (2023-11-01)

4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8+ T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling.
by: Ho S Oh, et al.
Published: (2015-01-01)

Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis
by: Shijian Zhao, et al.
Published: (2022-06-01)

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
by: Dvorakova, T, et al.
Published: (2024)

Qa-1-Restricted CD8+ T Cells Can Compensate for the Absence of Conventional T Cells during Viral Infection
by: Courtney K. Anderson, et al.
Published: (2019-04-01)

SARS-CoV-2 CD8+ T cell killing assays using replicating viruses and transgenic antigens
by: Laura M. Mateyka, et al.
Published: (2022-12-01)

442-K A CAR T cell approach for treating B cell lineage cancers expressing membrane IgE
by: Shenyu Zhang, et al.
Published: (2023-11-01)

CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture
by: Maraike Harfmann, et al.
Published: (2024-01-01)

Fiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existence.
by: Johan Rebetz, et al.
Published: (2009-12-01)

Identifying the Spatial Architecture That Restricts the Proximity of CD8<sup>+</sup> T Cells to Tumor Cells in Pancreatic Ductal Adenocarcinoma
by: Yihan Xia, et al.
Published: (2024-04-01)

Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
by: Letizia Polito, et al.
Published: (2017-05-01)

Characterization of the TCRβ repertoire of peripheral MR1-restricted MAIT cells in psoriasis vulgaris patients
by: Maja Jirouš Drulak, et al.
Published: (2023-11-01)

395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM™) adoptive cell therapy (ACT) T cells
by: Rui Wang, et al.
Published: (2023-11-01)

The new immunosuppression: just kill the T cell.
by: Waldmann, H
Published: (2003)

442-D OUTLAST™ CAR-T cells exhibit superior effector function against solid tumors
by: Sumiti Jain, et al.
Published: (2023-11-01)

442-G Metabolic reprogramming regulates anti-tumor effects of engineered CAR/TCR T cells
by: Xiaoyu Zhang, et al.
Published: (2023-11-01)

CD8[superscript +] T-cell Responses Rapidly Select for Antigen-Negative Tumor Cells in the Prostate
by: Bak, S. Peter G., et al.
Published: (2014)

IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing
by: Sara Andreone, et al.
Published: (2019-10-01)